Clinical Trial Update: Paclitaxel Plus Gemcitabine in Treating Patients With Refractory Metastatic Germ Cell Tumors [Phase 2]

View source ↗

Summary

Phase 2 trial updating Paclitaxel plus Gemcitabine in refractory metastatic germ cell tumors (testicular germ cell tumors) and ovarian cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer
• Testicular Germ Cell Tumor

Drugs mentioned

• Gemcitabine (Gemcitabine)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Ovarian Cancer, Testicular Germ Cell Tumor | Phase 2 | Status: COMPLETED